Close

Petros Pharmaceuticals Welcomes Dr. Mohit Khera to Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. BSX


Go back to Petros Pharmaceuticals Welcomes Dr. Mohit Khera to Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)
(NASDAQ: PTPI) Delayed: 0.64 +0.01 (1.59%)
Previous Close $0.63    52 Week High $ 
Open $0.64    52 Week Low $ 
Day High $0.65    P/E N/A 
Day Low $0.60    EPS $ 
Volume 225,251